CoreCap Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52.9K Buy
275
+255
+1,275% +$41.5K ﹤0.01% 1368
2026
Q2
$2.73K Hold
20
– – ﹤0.01% 2456
2026
Q1
$2.36K Hold
20
– – ﹤0.01% 2374
2025
Q4
$3.28K Buy
+20
New +$3.13K ﹤0.01% 2345
2025
Q2
– Sell
-1
Closed -$127 – 3161
2025
Q1
$127 Buy
+1
New +$154 ﹤0.01% 3042
2022
Q1
– Sell
-125
Closed -$33K – 1730
2021
Q4
$33K Buy
+125
New +$33.7K ﹤0.01% 1140

Other funds holding RGEN

CoreCap Advisors's RGEN Position: Q3 2026 in Review

CoreCap Advisors increased its Repligen (RGEN) stake by 1,275% in Q3 2026, buying an estimated $41.5K and bringing the position to 275 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.

CoreCap Advisors first reported a position in RGEN in Q4 2021 and has held it in 6 quarters since. 85 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • CoreCap Advisors held 275 shares of Repligen worth $52.9K as of Q3 2026.
  • CoreCap Advisors bought 255 Repligen shares in Q3 2026, an estimated $41.5K.
  • Repligen made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1368 holding.
  • CoreCap Advisors first reported a position in Repligen in Q4 2021 and has held it in 6 quarters since.
  • 85 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.